UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

Nature medicine, 2020-09, Vol.26 (9), p.1468-1479

2020

Volltextzugriff (PDF)

The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma

PloS one, 2015-03, Vol.10 (3), p.e0120734-e0120734

2015

Volltextzugriff (PDF)

CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas

Haematologica (Roma), 2020-05, Vol.105 (5), p.1361-1368

2020

Volltextzugriff (PDF)

Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion

Blood advances, 2019-12, Vol.3 (23), p.4065-4080

2019

Volltextzugriff (PDF)

The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients

Blood Research, 2021, 56(3), , pp.156-165

2021

Volltextzugriff (PDF)

Biomarkers for immune checkpoint blockers

HemaSphere, 2018-06, Vol.2 (S2), p.90-92

2018

Volltextzugriff (PDF)

Abstract B18: MAGEC1 and BAGE2 mRNA expression can be used to monitor chemotherapy treatment responses in multiple myeloma patients and pre-empt clinical relapse

Cancer research (Chicago, Ill.), 2017-11, Vol.77 (22_Supplement), p.B18-B18

2017

Volltextzugriff (PDF)

The use of Cancer/Testis antigens to monitor levels of circulating malignant stem cells in Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e182-e182

2019

Volltextzugriff (PDF)

Cancer testis antigen MAGE C1 can be used to monitor levels of circulating malignant stem cells in the peripheral blood of multiple myeloma patients

Journal of cancer research and clinical oncology, 2016-11, Vol.142 (11), p.2383-2396

2016

Volltextzugriff (PDF)

Molecular classification of aggressive lymphomas—past, present, future

Hematological oncology, 2021-06, Vol.39 (S1), p.24-30

2021

Volltextzugriff (PDF)

Molecular Classification of Large B-Cell Non-Hodgkin Lymphoma

The cancer journal (Sudbury, Mass.), 2020-07, Vol.26 (4), p.357-361

2020

Volltextzugriff (PDF)

Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL

Blood, 2019-01, Vol.133 (1), p.70-80

2019

Volltextzugriff (PDF)

Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment

Blood, 2018-08, Vol.132 (8), p.825-836

2018

Volltextzugriff (PDF)

Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade

Blood, 2019-12, Vol.134 (26), p.2369-2382

2019

Volltextzugriff (PDF)

Validation of the Genetically-Defined DLBCL Subtypes and Generation of a Parsimonious Probabilistic Classifier

Blood, 2019-11, Vol.134 (Supplement_1), p.920-920

2019

Volltextzugriff (PDF)

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

Nature communications, 2021-08, Vol.12 (1), p.5183-5183, Article 5183

2021

Volltextzugriff (PDF)

Targeted Inhibition of PI3K α/δ Is Synergistic with BCL-2 Blockade in Genetically Defined Subtypes of DLBCL

Blood, 2018-11, Vol.132 (Supplement 1), p.39-39

2018

Volltextzugriff (PDF)

The Use of MAGE C1 and Flow Cytometry to Determine the Malignant Cell Type in Multiple Myeloma: e0120734

PloS one, 2015-03, Vol.10 (3)

2015

Volltextzugriff (PDF)

Abstract LB074: Towards the next generation cancer dependency map

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB074-LB074

2023

Volltextzugriff (PDF)

Comprehensive Genomic Analysis of Primary Mediastinal B-Cell Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.1564-1564

2018

Volltextzugriff (PDF)

Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade

Blood, 2019-11, Vol.134 (Supplement_1), p.1493-1493

2019

Volltextzugriff (PDF)

Abstract LB234: Identifying cancer vulnerabilities associated with changes in chromatin accessibility by simultaneously profiling hundreds of cancer cell lines with ATAC-seq

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB234-LB234

2024

Volltextzugriff (PDF)

Comprehensive Genomic Analysis of Flow-Sorted Hodgkin Reed Sternberg Cells Reveals Additional Genetic Bases of Immune Evasion

Blood, 2018-11, Vol.132 (Supplement 1), p.1559-1559

2018

Volltextzugriff (PDF)

Abstract 5675: Single-cell mass cytometry of classical Hodgkin lymphoma defines an exhausted and immunosuppressive microenvironment

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5675-5675

2018

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(11)
Hematology
(10)
Humans
(7)
Female
(4)
Lymphoid Neoplasia
(4)
Lymphoma
(4)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(3)
Lymphoma, Large B-Cell, Diffuse - Genetics
(3)
Male
(3)
Oncology
(3)
Patients
(3)
Adult
(2)
Aged
(2)
Aged, 80 And Over
(2)
Antigens
(2)
Antineoplastic Agents, Immunological - Therapeutic Use
(2)
Biomarker
(2)
Biomarkers, Tumor - Biosynthesis
(2)
Cytometry
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(8)
Cancer Research
(4)
Plos One
(2)
Blood Advances
(1)
Blood Research
(1)
Clinical Lymphoma, Myeloma And Leukemia
(1)
Haematologica
(1)
Hemasphere
(1)
Hematological Oncology
(1)
Journal Of Cancer Research And Clinical Oncology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma

CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas

Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion

The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients

Biomarkers for immune checkpoint blockers

Abstract B18: MAGEC1 and BAGE2 mRNA expression can be used to monitor chemotherapy treatment responses in multiple myeloma patients and pre-empt clinical relapse

The use of Cancer/Testis antigens to monitor levels of circulating malignant stem cells in Multiple Myeloma

Cancer testis antigen MAGE C1 can be used to monitor levels of circulating malignant stem cells in the peripheral blood of multiple myeloma patients

Molecular classification of aggressive lymphomas—past, present, future

Molecular Classification of Large B-Cell Non-Hodgkin Lymphoma

Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL

Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment

Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade

Validation of the Genetically-Defined DLBCL Subtypes and Generation of a Parsimonious Probabilistic Classifier

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

Targeted Inhibition of PI3K α/δ Is Synergistic with BCL-2 Blockade in Genetically Defined Subtypes of DLBCL

The Use of MAGE C1 and Flow Cytometry to Determine the Malignant Cell Type in Multiple Myeloma: e0120734

Abstract LB074: Towards the next generation cancer dependency map

Comprehensive Genomic Analysis of Primary Mediastinal B-Cell Lymphoma

Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade

Abstract LB234: Identifying cancer vulnerabilities associated with changes in chromatin accessibility by simultaneously profiling hundreds of cancer cell lines with ATAC-seq

Comprehensive Genomic Analysis of Flow-Sorted Hodgkin Reed Sternberg Cells Reveals Additional Genetic Bases of Immune Evasion

Abstract 5675: Single-cell mass cytometry of classical Hodgkin lymphoma defines an exhausted and immunosuppressive microenvironment

Suchergebnisse filtern